CD151 inhibitors

A compound of Formula (I):

• Formula (I)
• wherein
• R1, R2, and R3 are each independently selected from the group consisting of H and C1-C12alkyl,
• R4 is selected from the group consisting of H and C1-C12alkyl,
• R5 is selected from the group consisting of H, optionally substituted C6-C18aryl, optionally substituted C1-C18heteroaryl, optionally substituted C6-C18arylC1-C12alkyl-, and optionally substituted C1-C18heteroarylC1-C12alkyl-;
• R6 is selected from the group consisting of H, C1-C12alkyl, C3-C6 cycloalkyl, and C1-C5 heterocycloalkyl,
• R7 is selected from the group consisting of H and C1-C12alkyl;
• R8 is selected from the group consisting of H, C1-C12alkyl, optionally substituted C6-C18aryl, optionally substituted C1-C18heteroaryl, optionally substituted C6-C18arylC1-C12alkyl-, and optionally substituted C1-C18heteroarylC1-C12alkyl-;
• or R7 and R8 when taken together with the nitrogen atom to which they are attached form an optionally substituted C2-C12heterocyclic group;
• or a pharmaceutically acceptable salt thereof.